Lung Disease News |
Glaxo's asthma drug Nucala gets Japanese approval
MarketWatch The Japanese Ministry of Health, Labour and Welfare granted approval for the drug "as a treatment for bronchial asthma in patients with refractory asthma whose symptoms are inadequately controlled with standard treatment," Glaxo said Tuesday. FDA Approves Teva's Asthma Drug Cinqair as Add-on Treatment GSK: Nucala Receives Approval In Japan For Treatment Of Bronchial Asthma Nucala and Cinqair for the Treatment of Severe Asthma |
View full post on asthma – Google News